Navigation Links
MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R)
Date:8/26/2009

ocet(R), which contains an opioid (oxycodone) combined with acetaminophen (like Tylenol(R)) have been the subject of recent FDA scrutiny due to their potential for causing significant adverse effects on liver and gastrointestinal function.

To date, more than 400 patients in six clinical trials have received MoxDuo IR for different forms of post-surgical pain (bunionectomy and total knee replacement). Study results with MoxDuo(TM) IR consistently demonstrate fewer side effects than observed with morphine alone, oxycodone alone and now with Percocet(R).

In this open label trial, each group of patients who experienced moderate to severe post-operative pain following total knee replacement surgery were treated every four to six hours over a 48-hour period. The study enrolled a total of 44 patients at five US clinical research sites.

All primary study objectives were met comparing: (1) the analgesic efficacy and safety profile of MoxDuo(TM) IR against control groups of patients receiving Percocet(R), a frequently used opioid for the treatment of pain; and (2) a flexible dosing regimen of MoxDuo(TM) IR against a fixed low dose (3/2mg). Patients receiving the flexible dosing regimen of MoxDuo(TM) IR achieved significantly greater pain relief than those receiving the low dose formulation (p<0.05).

Data collected from this study provide additional guidance for optimising the design and implementation of pending pivotal Phase 3 studies as the Company prepares for New Drug Application (NDA) filings with the US Food and Drug Administration (FDA) in 2010.

MoxDuo(TM) IR, the Company's lead product candidate, is part of a larger Dual-Opioid portfolio including intravenous (MoxDuo(TM) IV) and controlled release (MoxDuo(TM) CR) formulations. These formulations are designed to incorporate tamper resistance and reduced abuse liability as appropriate.

Dr. Br
'/>"/>

SOURCE QRxPharma Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
2. Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class
3. Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
4. Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
5. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
6. Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
7. Study Demonstrates Efficacy of Pitavastatin in Elderly Patients
8. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
9. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
10. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
11. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, 2015, ... Oregon denied motions to dismiss securities ... GALE ) and certain of its directors. The class ... "pump and dump" scheme to artificially inflate Galena,s stock ... the stock price was inflated, sold massive amounts of ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... Mich., Oct. 19 Stryker Corporation (NYSE: SYK ... 2010 as follows: Third Quarter Highlights ... currency basis (6.9% as reported) to $1,768 million Orthopaedic ... as reported) MedSurg Equipment sales increased 16.3% on ...
... SCOTTSDALE, Ariz., Oct. 19 Matrixx Initiatives, Inc. (Nasdaq: ... financial results for the fiscal 2011 second quarter and six ... market closes on Monday, October 25, 2010. An earnings conference ... 26, 2010 at 11:00 AM ET. To access ...
Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results 2
(Date:9/1/2015)... ... September 01, 2015 , ... WorkCare, Inc., a national occupational ... management team as an Associate Medical Director. , WorkCare specializes in workforce ... U.S. and abroad. , Dr. Nelson has a diverse background. He trained ...
(Date:9/1/2015)... ... ... SC&H Group, a leading audit, tax, and consulting firm, received multiple honors from ... in the U.S., as well as being ranked a Top 100 Accounting Firm. , ... exclusively on performance in specific areas of financial and operational management. SC&H Group ...
(Date:9/1/2015)... ... September 01, 2015 , ... Mercy Health (formerly Catholic Health Partners) ... of its monthly Mercy Health: Helping You Be Well videos to prostate cancer awareness. ... , In a concise video on Mercy Health’s YouTube channel, Mercy Health experts ...
(Date:9/1/2015)... Miramar Beach, FL (PRWEB) , ... September 01, ... ... free pharmacy discount cards, launched its consumer-friendly, informational video this week to coincide ... country: http://www.USAMedicalCard.com/video . , According to the CDC, elementary school children ...
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Trace Curry successfully placed one ... In the last month the FDA has approved two intra-gastric balloons, the ... procedures represent the first incisionless, reversible, weight loss procedures available to Americans. ...
Breaking Medicine News(10 mins):Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2
... Inc. Magazine recently included,Connolly Consulting in its ... the country. The list is the most comprehensive ... -- America,s,independent-minded entrepreneurs. Taken as a whole, these ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081003/NY36880LOGO ), Connolly Consulting,s ...
... delivers The Breast Cancer Research Foundation(R) Collection of, ... Breast Cancer Research, LOS ANGELES, Oct. 3 ... hand-arranged, hand-delivered floral,arrangements by local Teleflora florists, announces ... Wayne Cancer Institute and the,UCLA Revlon Breast Cancer ...
... to be Featured in ... National Online Ad Campaign, DALLAS, Oct. 3 ... Strict definitions of motherhood no,longer apply, and mothers now have an ... anniversary, the Huggies brand,announces the Generation Huggies Program honoring today,s mom., ...
... My1Stop.com, America,s commercial printing superstore, provides business and ... magnets online. Comprising the expanded offering are six ... save-the-date magnets, special shaped magnets, framed magnets, calendar ... new custom magnets can be quoted by contacting ...
... CRDC ) today announced that Bernard A. Hausen, ... scheduled to present at,William Blair & Company,s 2008 Annual ... 2:00 p.m. Eastern Time. The conference will be,held at ... the live and subsequently archived webcast of the,presentation, go ...
... The presidential candidates,health care plans share some ... plan is likely to result in higher overall ... E. Thorpe, PhD, Emory,University health policy researcher., ... Emory,s Rollins,School of Public Health, is the author ...
Cached Medicine News:Health News:Connolly Consulting Makes the 2008 Inc. Magazine's List of America's 5000 Fastest Growing Companies 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 2Health News:Teleflora and Nationally Recognized Hospitals to Honor Women Battling Breast Cancer 3Health News:Generation Huggies Celebrates 30 Years With 30 Moms 2Health News:Generation Huggies Celebrates 30 Years With 30 Moms 3Health News:My1Stop.com Expands Custom Magnets Offering with Six New Promotional and Consumer Categories 2Health News:Emory Health Policy Expert Weighs in on Candidates' Health Care Plans 2Health News:Emory Health Policy Expert Weighs in on Candidates' Health Care Plans 3
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... Hoffmann® II Hybrid External Fixation System ... generation in hybrid fixation. It incorporates ... and is designed to offer speed ... patented Hoffmann® snap-fit technology. , ,Using ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
Medicine Products: